SanBio Co Ltd (SNBIF)
3.85
0.00 (0.00%)
USD |
OTCM |
Jun 14, 16:00
SanBio Free Cash Flow (Quarterly)
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2023 | -18.92M |
| April 30, 2023 | |
| January 31, 2023 | |
| October 31, 2022 | |
| July 31, 2022 | -29.94M |
| April 30, 2022 | |
| January 31, 2022 | |
| October 31, 2021 | |
| July 31, 2021 | -31.88M |
| April 30, 2021 | |
| January 31, 2021 | |
| October 31, 2020 | |
| July 31, 2020 | -24.15M |
| April 30, 2020 | |
| January 31, 2020 | |
| October 31, 2019 | |
| July 31, 2019 | -25.69M |
| Date | Value |
|---|---|
| April 30, 2019 | |
| January 31, 2019 | |
| October 31, 2018 | |
| July 31, 2018 | -19.39M |
| April 30, 2018 | |
| January 31, 2018 | |
| October 31, 2017 | |
| July 31, 2017 | -17.60M |
| April 30, 2017 | |
| January 31, 2017 | |
| October 31, 2016 | |
| July 31, 2016 | -6.253M |
| April 30, 2016 | |
| January 31, 2016 | |
| October 31, 2015 | |
| July 31, 2015 | -6.073M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-31.88M
Minimum
Jul 2021
-18.92M
Maximum
Jul 2023
-26.12M
Average
-25.69M
Median
Jul 2019
Free Cash Flow (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 1.488B |
| Nxera Pharma Co Ltd | -15.19M |
| PeptiDream Inc | -16.64M |
| Healios KK | -4.177M |
| AnGes Inc | -- |